Michael P. Dutro

505 total citations
10 papers, 336 citations indexed

About

Michael P. Dutro is a scholar working on Surgery, Nephrology and Pharmacology. According to data from OpenAlex, Michael P. Dutro has authored 10 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Surgery, 2 papers in Nephrology and 2 papers in Pharmacology. Recurrent topics in Michael P. Dutro's work include Pharmacological Effects and Toxicity Studies (2 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Michael P. Dutro is often cited by papers focused on Pharmacological Effects and Toxicity Studies (2 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Michael P. Dutro collaborates with scholars based in United States and United Kingdom. Michael P. Dutro's co-authors include Douglas W. Mapel, Jenő P. Marton, Barry J. Make, Jon O. Ebbert, Ching‐Ray Yu, Cristina Russ, Thomas McRae, Robert West, Stephen I. Rennard and Peter W. Park and has published in prestigious journals such as JAMA, Mayo Clinic Proceedings and BMC Health Services Research.

In The Last Decade

Michael P. Dutro

10 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael P. Dutro United States	6	186	168	51	47	45	10	336
DP Tashkin United States	4	263 1.4×	213 1.3×	59 1.2×	37 0.8×	27 0.6×	11	393
Swarna Gaddam United States	4	182 1.0×	98 0.6×	19 0.4×	27 0.6×	19 0.4×	5	280
Dirk van Ranst Netherlands	9	64 0.3×	298 1.8×	12 0.2×	38 0.8×	10 0.2×	16	383
Á. Callejo Mellén Sweden	7	259 1.4×	248 1.5×	14 0.3×	19 0.4×	14 0.3×	15	381
Henna Kupiainen Finland	8	272 1.5×	353 2.1×	10 0.2×	40 0.9×	4 0.1×	10	420
Aikaterini Haniotou Greece	7	100 0.5×	217 1.3×	29 0.6×	29 0.6×	4 0.1×	14	304
Menfil Orellana-Barrios United States	7	221 1.2×	29 0.2×	38 0.7×	27 0.6×	45 1.0×	25	316
Jacques P.H.M. Creemers Netherlands	12	444 2.4×	476 2.8×	73 1.4×	15 0.3×	4 0.1×	18	635
Kohta Satake Japan	10	135 0.7×	73 0.4×	11 0.2×	23 0.5×	75 1.7×	15	315
Li Ping Chung Australia	11	261 1.4×	272 1.6×	25 0.5×	28 0.6×	3 0.1×	18	419

Countries citing papers authored by Michael P. Dutro

Since Specialization

Citations

This map shows the geographic impact of Michael P. Dutro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Dutro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Dutro more than expected).

Fields of papers citing papers by Michael P. Dutro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. Dutro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Dutro. The network helps show where Michael P. Dutro may publish in the future.

Co-authorship network of co-authors of Michael P. Dutro

This figure shows the co-authorship network connecting the top 25 collaborators of Michael P. Dutro. A scholar is included among the top collaborators of Michael P. Dutro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael P. Dutro. Michael P. Dutro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Ebbert, Jon O., et al.. (2021). Frequently Reported Adverse Events With Smoking Cessation Medications: Post Hoc Analysis of a Randomized Trial. Mayo Clinic Proceedings. 96(7). 1801–1811. 6 indexed citations

Ebbert, Jon O., John R. Hughes, Robert West, et al.. (2015). Effect of Varenicline on Smoking Cessation Through Smoking Reduction. JAMA. 313(7). 687–687. 142 indexed citations

Dutro, Michael P., et al.. (2012). Undertreatment of COPD: a retrospective analysis of US managed care and Medicare patients. International Journal of COPD. 7. 1–1. 88 indexed citations

Mapel, Douglas W., et al.. (2011). Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data. BMC Health Services Research. 11(1). 43–43. 67 indexed citations

Aronow, Herbert D., et al.. (2008). Prevalence of cardiovascular comorbidities and utilization of evidence-based treatment strategies among statin users in a Medicare and commercial health plan. Current Medical Research and Opinion. 25(1). 205–213. 5 indexed citations

Dutro, Michael P., et al.. (2007). Treatment of Hypertension and Dyslipidemia or Their Combination Among US Managed‐Care Patients. Journal of Clinical Hypertension. 9(9). 684–691. 16 indexed citations

Dutro, Michael P., et al.. (1992). Criteria for use of total parenteral nutrition administered by a central venous catheter in adults. Presbyterian Hospital, Albuquerque, New Mexico.. PubMed. 27(11). 963–7, 970. 5 indexed citations

Dutro, Michael P., et al.. (1981). Nafcillin-induced neutropenia in two children. American Journal of Health-System Pharmacy. 38(6). 889–892. 3 indexed citations

Blouin, Robert A., et al.. (1980). Chloramphenicol Hemodialysis Clearance. Therapeutic Drug Monitoring. 2(4). 351–354. 1 indexed citations

10.

Blouin, Robert A., et al.. (1980). Chloramphenicol Hemodialysis Clearance. Therapeutic Drug Monitoring. 2(4). 351–354. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact